Clinical Trials Browser

Phase 2/3 × Weight Loss × Nutrition Assessment × Clear all

NCT01048970 2010-01-14

Effect on the Nutritional and Inflammatory Status of Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)- Containing Supplement in Patients With Advanced Lung Cancer

Phase 2/3 Unknown

Lung Neoplasms, Weight Loss